Browsing Tag
psychedelic medicine
3 posts
Why next-generation MDMA therapeutics are becoming the new battleground in psychedelic biotech
Why next-generation MDMA therapeutics are reshaping psychedelic biotech strategy, investor expectations, and commercialization competition.
May 22, 2026
GMP psilocybin manufacturing supports growing psychedelic clinical pipeline
Psyence Biomedical Ltd. exports GMP psilocybin for a Phase IIb cancer trial. Discover what this means for psychedelic medicine and biotech investors.
March 6, 2026
Compass Pathways fast-tracks COMP360 launch timeline as Q3 2025 results show improved financial runway
Learn how Compass Pathways’ faster COMP360 launch timeline after Q3 2025 results could reshape the psychedelics industry and investor sentiment.
November 4, 2025